The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Carbapenem-Resistant Enterobacteriaceae
Open accessAbstract
Synopsis Carbapenem-resistant Enterobacteriaceae (CRE) have emerged as a major threat to modern medicine. Commonly used antibiotics are generally inactive against CRE. Therefore, timely detection of CRE in the clinical laboratory is of paramount importance. Among CRE, those producing carbapenem-hydrolyzing β-lactamase enzymes (carbapenemase-producing Enterobacteriaceae; CPE) are particularly of concern since they tend to spread among patients, and treatment of active infection is difficult. The carbapenemase groups most commonly encountered include KPC, NDM and OXA-48, with KPC overrepresented in the United States. Various phenotypic and genetic tests have been proposed and validated for rapid detection of CPE. Phenotypic tests detect carbapenemase activity either by inhibiting their activity with specific inhibitors of carbapenemases, or by detecting hydrolysis of carbapenems by carbapenemases. Genetic tests mostly depend on nucleic acid detection and amplification. Treatment options for CRE infections are limited and typically include combinations of polymyxins, tigecycline, aminoglycosides, or carbapenems, but newer agents with activity against CRE and better safety profiles are starting to become available and will likely emerge as the preferred therapy for the treatment of CRE infections in the near future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hidron, A. I., Edwards, J. R., Patel, J., Horan, T. C., Sievert, D. M., Pollock, D. A., Fridkin, S. K., & National Healthcare Safety Network Team and Participating National Healthcare Safety Network Facilities (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/591861 · Cited by 3,724
Extended-Spectrum β-Lactamases: a Clinical Update
Paterson, D. L., & Bonomo, R. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.657-686.2005 · Cited by 3,491
Kumarasamy, K. K., Toleman, M. A., Walsh, T. R., Bagaria, J., Butt, F., Balakrishnan, R., Chaudhary, U., Doumith, M., Giske, C. G., Irfan, S., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70143-2 · Cited by 2,922
Yong, D., Toleman, M. A., Giske, C. G., Cho, H. S., Sundman, K., Lee, K., & Walsh, T. R. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00774-09 · Cited by 2,519
Ambler, R. P. (1980) · Philosophical Transactions of the Royal Society of London. B, Biological Sciences · doi:10.1098/rstb.1980.0049 · Cited by 1,823
Yigit, H., Queenan, A. M., Anderson, G. J., Domenech-Sanchez, A., Biddle, J. W., Steward, C. D., Alberti, S., Bush, K., & Tenover, F. C. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.1151-1161.2001 · Cited by 1,639
Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
Munoz-Price, L. S., Poirel, L., Bonomo, R. A., Schwaber, M. J., Daikos, G. L., Cormican, M., Cornaglia, G., Garau, J., Gniadkowski, M., Hayden, M. K., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70190-7 · Cited by 1,627
Weiner, L. M., Webb, A. K., Limbago, B., Dudeck, M. A., Patel, J., Kallen, A. J., Edwards, J. R., & Sievert, D. M. (2016) · Infection Control & Hospital Epidemiology · doi:10.1017/ice.2016.174 · Cited by 1,313
Ten Great Public Health Achievements—United States, 1900-1999
(1999) · JAMA · doi:10.1001/jama.281.16.1481 · Cited by 1,298
Tumbarello, M., Viale, P., Viscoli, C., Trecarichi, E. M., Tumietto, F., Marchese, A., Spanu, T., Ambretti, S., Ginocchio, F., Cristini, F., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis588 · Cited by 1,016
Emergence of Oxacillinase-Mediated Resistance to Imipenem in Klebsiella pneumoniae
Poirel, L., Héritier, C., Tolün, V., & Nordmann, P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.15-22.2004 · Cited by 997
OXA-48-like carbapenemases: the phantom menace
Poirel, L., Potron, A., & Nordmann, P. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks121 · Cited by 924
Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance
Pitout, J. D. D., Nordmann, P., & Poirel, L. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01019-15 · Cited by 852
Rapid Detection of Carbapenemase-producing Enterobacteriaceae
Nordmann, P., Poirel, L., & Dortet, L. (2012) · Emerging Infectious Diseases · doi:10.3201/eid1809.120355 · Cited by 761
Lauretti, L., Riccio, M. L., Mazzariol, A., Cornaglia, G., Amicosante, G., Fontana, R., & Rossolini, G. M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1584 · Cited by 677
The emerging NDM carbapenemases
Nordmann, P., Poirel, L., Walsh, T. R., & Livermore, D. M. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.09.005 · Cited by 663
Bratu, S., Landman, D., Haag, R., Recco, R., Eramo, A., Alam, M., & Quale, J. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.12.1430 · Cited by 573
Paterson, D. L., Ko, W.-C., Von Gottberg, A., Mohapatra, S., Casellas, J. M., Goossens, H., Mulazimoglu, L., Trenholme, G., Klugman, K. P., Bonomo, R. A., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/420816 · Cited by 571
Carbapenemase-producing Klebsiella pneumoniae: molecular and genetic decoding
Chen, L., Mathema, B., Chavda, K. D., DeLeo, F. R., Bonomo, R. A., & Kreiswirth, B. N. (2014) · Trends in Microbiology · doi:10.1016/j.tim.2014.09.003 · Cited by 554
Worldwide Dissemination of the NDM-Type Carbapenemases in Gram-Negative Bacteria
Dortet, L., Poirel, L., & Nordmann, P. (2014) · BioMed Research International · doi:10.1155/2014/249856 · Cited by 501
van der Zwaluw, K., de Haan, A., Pluister, G. N., Bootsma, H. J., de Neeling, A. J., & Schouls, L. M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0123690 · Cited by 486
Bradford, P. A., Bratu, S., Urban, C., Visalli, M., Mariano, N., Landman, D., Rahal, J. J., Brooks, S., Cebular, S., & Quale, J. (2004) · Clinical Infectious Diseases · doi:10.1086/421495 · Cited by 485
Osano, E., Arakawa, Y., Wacharotayankun, R., Ohta, M., Horii, T., Ito, H., Yoshimura, F., & Kato, N. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.1.71 · Cited by 440
Shields, R. K., Potoski, B. A., Haidar, G., Hao, B., Doi, Y., Chen, L., Press, E. G., Kreiswirth, B. N., Clancy, C. J., & Nguyen, M. H. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw636 · Cited by 430
Self-citationEpstein, L., Hunter, J. C., Arwady, M. A., Tsai, V., Stein, L., Gribogiannis, M., Frias, M., Guh, A. Y., Laufer, A. S., Black, S., et al. (2014) · JAMA · doi:10.1001/jama.2014.12720 · Cited by 400
Ten great public health achievements--United States, 1900-1999.
(1999) · PubMed · Cited by 371
Laboratory Detection of Enterobacteriaceae That Produce Carbapenemases
Doyle, D., Peirano, G., Lascols, C., Lloyd, T., Church, D. L., & Pitout, J. D. D. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.02117-12 · Cited by 363
Evaluation of Methods To Identify the Klebsiella pneumoniae Carbapenemase in Enterobacteriaceae
Anderson, K. F., Lonsway, D. R., Rasheed, J. K., Biddle, J., Jensen, B., McDougal, L. K., Carey, R. B., Thompson, A., Stocker, S., Limbago, B., et al. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00015-07 · Cited by 355
Treating infections caused by carbapenemase-producing Enterobacteriaceae
Tzouvelekis, L. S., Markogiannakis, A., Piperaki, E., Souli, M., & Daikos, G. L. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12697 · Cited by 337
Potron, A., Poirel, L., Rondinaud, E., & Nordmann, P. (2013) · Eurosurveillance · doi:10.2807/1560-7917.es2013.18.31.20549 · Cited by 289
Carbapenemase-Producing Enterobacteriaceae
Paterson, D., & Doi, Y. (2015) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0035-1544208 · Cited by 257
Self-citationKohira, N., West, J., Ito, A., Ito-Horiyama, T., Nakamura, R., Sato, T., Rittenhouse, S., Tsuji, M., & Yamano, Y. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01695-15 · Cited by 247
Salimnia, H., Fairfax, M. R., Lephart, P. R., Schreckenberger, P., DesJarlais, S. M., Johnson, J. K., Robinson, G., Carroll, K. C., Greer, A., Morgan, M., et al. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.01679-15 · Cited by 243
Franklin, C., Liolios, L., & Peleg, A. Y. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00879-06 · Cited by 227
Bowers, J. R., Kitchel, B., Driebe, E. M., MacCannell, D. R., Roe, C., Lemmer, D., de Man, T., Rasheed, J. K., Engelthaler, D. M., Keim, P., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0133727 · Cited by 209
Spotlight on ceftazidime/avibactam: a new option for MDR Gram-negative infections
Falcone, M., & Paterson, D. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw239 · Cited by 180
Castanheira, M., Farrell, S. E., Krause, K. M., Jones, R. N., & Sader, H. S. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01896-13 · Cited by 177
Ledeboer, N. A., Lopansri, B. K., Dhiman, N., Cavagnolo, R., Carroll, K. C., Granato, P., Thomson, R., Butler-Wu, S. M., Berger, H., Samuel, L., et al. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.00581-15 · Cited by 164
The inhibition of class C β-lactamases by boronic acids
Beesley, T., Gascoyne, N., Knott-Hunziker, V, Petursson, S., Waley, S. G., Jaurin, B., & Grundström, T. (1983) · Biochemical Journal · doi:10.1042/bj2090229 · Cited by 159
Tato, M., Ruíz-Garbajosa, P., Traczewski, M. M., Dodgson, A. R., McEwan, A. K., Humphries, R. M., Hindler, J. A., Veltman, J., Wang, H., & Cantón, R. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.00341-16 · Cited by 150
Doi, Y., Potoski, B. A., Adams‐Haduch, J. M., Sidjabat, H. E., Pasculle, A. W., & Paterson, D. L. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.01408-08 · Cited by 147
Self-citationOvercoming differences: The catalytic mechanism of metallo‐β‐lactamases
Meini, M.-R., Llarrull, L. I., & Vila, A. J. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.08.015 · Cited by 145
New Delhi Metallo-β-Lactamase–producingEnterobacteriaceae, United States
Rasheed, J. K., Kitchel, B., Zhu, W., Anderson, K. F., Clark, N. C., Ferraro, M. J., Savard, P., Humphries, R. M., Kallen, A. J., & Limbago, B. M. (2013) · Emerging infectious diseases · doi:10.3201/eid1906.121515 · Cited by 145
Thaden, J. T., Pogue, J. M., & Kaye, K. S. (2016) · Virulence · doi:10.1080/21505594.2016.1207834 · Cited by 134
Lasserre, C., Martin, L. D. S., Cuzon, G., Bogaerts, P., Lamar, E., Glupczynski, Y., Naas, T., & Tandé, D. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.03467-14 · Cited by 122
González-Padilla, M., Torre‐Cisneros, J., Rivera-Espinar, F., Pontes-Moreno, A., López‐Cerero, L., Pascual, Á., Natera, C., Rodriguez, M., Salcedo-Leal, I., Rodríguez-López, F., et al. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku432 · Cited by 104
High Incidence and Endemic Spread of NDM-1-Positive Enterobacteriaceae in Henan Province, China
Qin, S., Fu, Y., Zhang, Q., Qi, H., Wen, J., Xu, H., Xu, L., Zeng, L., Tian, H., Rong, L., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02813-13 · Cited by 95
Hill, J. T., Tran, K.-D. T., Barton, K., Labreche, M. J., & Sharp, S. E. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.01537-14 · Cited by 77
Aitken, S. L., Tarrand, J. J., Deshpande, L. M., Tverdek, F. P., Jones, A. L., Shelburne, S. A., Prince, R. A., Bhatti, M. M., Rolston, K. V. I., Jones, R. N., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw398 · Cited by 68
Rand, K. H., & Delano, J. P. (2014) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2014.03.014 · Cited by 66
Rapid detection of carbapenemase activity: benefits and weaknesses of MALDI-TOF MS
Mirande, C., Canard, I., Buffet, S., Charrier, J., van Belkum, A., Welker, M., & Chatellier, S. (2015) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-015-2473-z · Cited by 56
New Developments in Clinical Bacteriology Laboratories
Patel, R. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.06.020 · Cited by 55
Ke, W., Bethel, C. R., Papp‐Wallace, K. M., Pagadala, S. R. R., Nottingham, M., Fernández, D., Buynak, J. D., Bonomo, R. A., & van den Akker, F. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06099-11 · Cited by 51
Lyman, M., Walters, M. S., Lonsway, D. R., Rasheed, J. K., Limbago, B. M., & Kallen, A. J. (2015) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6447a3 · Cited by 39
Epson, E. E., Pisney, L. M., Wendt, J. M., MacCannell, D., Janelle, S. J., Kitchel, B., Rasheed, J. K., Limbago, B. M., Gould, C. V., Kallen, A. J., et al. (2014) · Infection Control and Hospital Epidemiology · doi:10.1086/675607 · Cited by 38
Monteferrante, C. G., Sultan, S., ten Kate, M. T., Dekker, L. J. M., Sparbier, K., Peer, M., Kostzrewa, M., Luider, T. M., Goessens, W. H. F., & Burgers, P. C. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw208 · Cited by 36
Borah, V. V., Saikia, K. K., Chandra, P., Hazarika, N. K., & Chakravarty, R. (2016) · Indian Journal of Medical Microbiology · doi:10.4103/0255-0857.176853 · Cited by 19
Cited by
Han, R., Shi, Q., Wu, S., Yin, D., Peng, M., Dong, D., Zheng, Y., Guo, Y., Zhang, R., Hu, F., et al. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00314 · Cited by 386
Cefiderocol: Discovery, Chemistry, and In Vivo Profiles of a Novel Siderophore Cephalosporin
Sato, T., & Yamawaki, K. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz826 · Cited by 379
Yaghoubi, S., Zekiy, A. O., Krutova, M., Gholami, M., Kouhsari, E., Sholeh, M., Ghafouri, Z., & Maleki, F. (2022) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-04121-1 · Cited by 332
Menz, B. D., Charani, E., Gordon, D. L., Leather, A. J., Moonesinghe, S. R., & Phillips, C. J. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s319780 · Cited by 118
Metadata
- Authors
- Iovleva, A., & Doi, Y.
- Venue
- Clinics in Laboratory Medicine
- Publisher
- Elsevier BV
- Published
- 2017-06
- Volume
- 37
- Issue
- 2
- Pages
- 303-315
- ISSN
- 0272-2712 (ISSN-L)
- OpenAlex
- W2594502881
- Cited by
- 263
- References
- 57
- FWCI
- 8.04
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.